Skip to main content

Boston Scientific guidance

  • BSX · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$43.69−1.47%Close 16 Nov 2026 · Market value $62.69B

Boston Scientific gives no forecast in figures in its latest earnings release (28 Oct 2026). Many companies give their outlook on the call only, or none at all.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Guidance against results above 5 · within 2 · below 5

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
EPS · AdjustedFY2026$3.28 to $3.32Lowered twice—To come
EPS · AdjustedQ3 FY2026$0.80 to $0.82Given once$0.73Below the range
EPS · AdjustedQ2 FY2026$0.82 to $0.84Given once$0.86Above the range
EPS · AdjustedQ1 FY2026$0.78 to $0.80Given once$0.80Within the range
EPS · GAAPFY2025$1.97 to $2.01Raised twice$1.94Below the range
EPS · GAAPQ4 FY2025$0.48 to $0.52Given once$0.45Below the range
EPS · AdjustedQ4 FY2025$0.77 to $0.79Given once$0.80Above the range
EPS · GAAPQ3 FY2025$0.44 to $0.46Given once$0.51Above the range
EPS · AdjustedQ3 FY2025$0.70 to $0.72Given once$0.75Above the range
EPS · GAAPQ2 FY2025$0.45 to $0.47Given once$0.53Above the range
EPS · GAAPQ1 FY2025$0.43 to $0.45Given once$0.45Within the range
EPS · GAAPFY2024$1.28 to $1.30Given once$1.25Below the range
EPS · GAAPQ4 FY2024$0.41 to $0.43Given once$0.38Below the range

BSX in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.